article thumbnail

Novel Tricuspid Valve Procedure Improves Patients' Quality of Life and Health Status

DAIC

Blood then flows backwards within the heart and may cause symptoms such as shortness of breath and swelling in the abdomen, legs or veins in the neck.

Tricuspid 105
article thumbnail

Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery

DAIC

Tricuspid regurgitation is a condition where the tricuspid valve, located between the right atrium and right ventricle of the heart, fails to close properly, allowing blood to flow backward. This can lead to symptoms such as severe shortness of breath, swelling in the legs and abdomen and a significant reduction in quality of life.

article thumbnail

Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

DAIC

“Patients with severely calcified mitral stenosis are often not candidates for conventional open-heart surgery,” said Dr. Giustino. This minimally invasive technique pioneered at Henry Ford is a promising and safe treatment option for these patients to improve their cardiac symptoms and quality of life."

article thumbnail

Twelve-month follow-up effects of cognitive training after heart valve surgery on cognitive functions and health-related quality of life: a randomised clinical trial

Open Heart

Objectives Postoperative cognitive decline (POCD) or decreased health-related quality of life (HQL) have been reported after cardiac surgery. A previous investigation showed beneficial effects of postoperative cognitive training on POCD and HQL 3 months after heart surgery. Here, we present the 12-month follow-up results.

article thumbnail

New Treatment Options Available for Patients with Tricuspid Valve Disease

DAIC

How has treatment for tricuspid valve disease evolved? Makkar: For decades, tricuspid regurgitation was largely overlooked, often addressed only during surgeries for other heart valves. We prioritize improving quality of life, particularly for patients experiencing severe fatigue and breathlessness.

article thumbnail

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

DAIC

Highlights include: Due to the aging population and improvement in diagnostic strategies, the prevalence of heart valve disease is expected to double by 2040 and triple by 2060.As As a result, it is estimated that the number of patients requiring heart valve interventions will increase significantly in the coming decades.

article thumbnail

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

The panel's vote will be considered by the FDA when making a decision regarding the approval of TriClip, a first-of-its-kind minimally invasive device specifically designed to treat the difficult-to-access tricuspid valve. chief medical officer and divisional vice president of medical affairs of Abbott's structural heart business.

Tricuspid 102